17

Bevacizumab in advanced breast cancer: an opportunity as second-line therapy?

Year:
2012
Language:
english
File:
PDF, 239 KB
english, 2012
20

Anti-EGFR–targeting agents in recurrent or metastatic head and neck carcinoma: A meta-analysis

Year:
2012
Language:
english
File:
PDF, 519 KB
english, 2012
44

FOLFIRI with cetuximab or bevacizumab: FIRE-3

Year:
2014
Language:
english
File:
PDF, 51 KB
english, 2014